Echocardiography indicators in patients with atherosclerosis of peripheral arteries of the lower extremities dependent on T(–786)C polymorphism of the endothelial nitric oxide synthase gene promoter

 V.I. Tseluyko, O.D. Yarova

References 

1. Nechesova TA, Korobko IY, Kuznetsova NI. Remodeling of the left ventricle: pathogenesis and evaluation methods. Medicinskiie novosti. 2008;11:7-13. (in Russ.).
2. Parkhomenko ОМ, Lutai YаM, Irkin OI. Clinical and prognostic value of polymorphism of endothelial NO synthetase gene in patients with acute coronary syndromes. Emergency medicine. 2014;3(58):45-54. (in Russ.).
3. Recommendations for echocardiographic evaluation of left ventricular diastolic function. Recommendations of the Working Group on Functional Diagnostics of the Association of Cardiologists of Ukraine and the All-Ukrainian Association of Specialists in Echocardiography. 2016. webcardio.org. (in Ukr.).
4. Tsuleuko VYu, Yakovleva LM, Luchkov AB. Indicators of intracardiac hemodynamics in patients with coronary heart disease depending on the polymorphism of the T(-786)C promoter of the endothelial NO synthase gene. Emergency medicine. 2013;8(55): 99-104. (in Ukr.).
5. Bouisset F, Bongard V, Ruidavets JB. et al. Prognostic usefulness of clinical and subclinical peripheral arterial disease in men with stable coronary heart disease. Amer J Cardiology. 2012;110(2):197-202.
6. Forstermann U. Nitric oxide and oxidative stress in vascular disease. Eur J Physiology. 2010;459:923-939.
7. Fowkes F, Rudan P, Aboyans V. et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329-1340.
8. Fumihiko Kamezaki, Masato Tsutsui, Masao Takahashi et al. Plasma levels of nitric oxide metabolites are markedly reduced in normotensive men with electrocardiographically determined left ventricular hypertrophy. Hypertension. 2014;64:516-522.
9. Jiangping S, Zhe Z, Wei W. et al. Assessment of coronary artery stenosis by coronary angiography. Circulation. 2013;6:262-268.
10. Kablak-Ziembicka A, Przewlocki T, Pieniazek P. et al. The role of carotid intima-media thickness assessment in cardiovascular risk evaluation in patients with polyvascular atherosclerosis. Atherosclerosis. 2010;209(1):125-130.
11. Lang RM, Badano LP, Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J. 2015;16:233-271.
12. Mahmoodi K, Soltanpour M, Kamali K. Assessment of the role of plasma nitric oxide levels, T(–786)C genetic polymorphism, and gene expression levels of endothelial nitric oxide synthase in the development of coronary artery disease. Intern J Research Med Sciences. 2017;22:34.
13. Peach G, Griffin M, Jones K. et al. Diagnosis and management of peripheral arterial disease. Brit Med J. 2012;345:36-41.
14. REACH Registry Investigators. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. J Amer Med Association. 2010;304(12):1350-1357.
15. Salimi S, Naghavi A, Firoozrai M. Association of plasma nitric oxide concentration and endothelial nitric oxide synthase T(–786)C gene polymorphism in coronary artery disease. Pathophysiology. 2012;19(3):157-162.
16. Thygesen K, Alpert J, Jaffe A. et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020-2203.
17. Tosaka A, Ishihara T, Iida O. et al. Angiographic evaluation and clinical risk factors of coronary artery disease in patients with peripheral artery disease. J Amer Coll Cardiology. 2014;63(12).
18. Ward P, Goonewardena S, Lammertin G. et al. Comparison of the frequency of abnormal cardiac findings by echocardiography in patients with and without peripheral arterial disease. Amer J Cardiology. 2007;99(4):499-503.